Launched in 2021, Juisci makes it easier for healthcare professionals and medical businesses to share and access scientific information. The app lets doctors and researchers follow the latest scientific news with content tailored to their specialty, while companies can keep their teams informed and build engaged professional communities. With over 100,000 users in more than 60 countries, Juisci is helping make scientific knowledge more accessible across the medical world.
Juisci
Juisci makes medical publications more accessible and understandable for the medical community.
Founder.s
Robin Roumengas, David Luu & Tugdual de Kerviler
Located
Neuilly-sur-Seine, FR
Website
Fund
Socials
The challenge they want to solve
Medical professionals face an overwhelming volume of scientific research, making it difficult to stay updated on the latest advances relevant to their specialties. This information overload leads to knowledge gaps, inefficient workflows, and missed opportunities for improving patient care. Meanwhile, pharmaceutical companies and medical institutions also struggle to keep their teams informed and engaged with the most relevant scientific developments, often relying on costly and time-consuming content production methods.
The impact they have
Juisci makes scientific knowledge more accessible, digestible, and actionable by leveraging AI to deliver high-quality summaries of medical research. The platform empowers healthcare professionals to stay up-to-date quickly, at no cost, while supporting pharmaceutical companies and institutions with targeted scientific communication. By streamlining access to trustworthy information, Juisci enhances evidence-based practice, supports continuing education, and helps fight medical misinformation in a complex digital ecosystem.
The way we measure it
We measure it through: the number of healthcare professionals accessing free research summaries, the number of medical institutions and associations onboarded to the platform, the internal indicators of content quality and relevance, based on user engagement and expert validation.
